Elevated expression of IRS2 in the progression from neurofibroma to malignant peripheral nerve sheath tumor

Anticancer Research

Volumn 32, Issue 2, 2012, Pages 439-443

  Shaw, Christiana M ^a   Grobmyer, Stephen R ^a   Deniza, Ucar ^a   Cance, William G ^b   Reith, John D ^a   Hochwald, Steven N ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

FAK; IGF1R; IRS2; MPNST; Neurofibroma; Oncogenic proteins; VEGFR3

Indexed keywords

FOCAL ADHESION KINASE; INSULIN RECEPTOR SUBSTRATE 2; ONCOPROTEIN; SOMATOMEDIN C RECEPTOR; VASCULOTROPIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; NERVE SHEATH TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; PERIPHERAL NERVE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FOCAL ADHESION KINASE 1; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN RECEPTOR SUBSTRATE PROTEINS; NEOPLASM STAGING; NERVE SHEATH NEOPLASMS; NEUROFIBROMA; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84856813738     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Vincent AM and Feldman EL: Control of cell survival by IGF signaling pathways. Growth Horm IGF Res 12: 193-197, 2002. (Pubitemid 35230190)
2. Pollak M: (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8: 915-928, 2008.
3. Chang Q, Li Y, White MF, Fletcher JA and Xiao S: Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. Cancer Res 62: 6035-6038, 2002. (Pubitemid 35244449)
4. Maki RG: Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. J Clin Oncol 28: 4985-4995, 2010.
5. Schaller MD: Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta 1540: 1-21, 2001.
6. Hochwald SN and Golubovskaya GV: FAK as a taget for cancer therapy. Gene TherMol Biol 13: 26-35, 2009.
7. Schlaepfer DD and Mitra SK: Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 14: 92-101, 2004. (Pubitemid 38167483)
8. Liu W, Bloom DA, Cance WG, Kurenova EV, Golubovskaya VM and Hochwald SN: FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells. Carcinogenesis 29: 1096-1107, 2008. (Pubitemid 351958687)
9. Zheng D, Golubovskaya V, Kurenova E, Wood C, Massoll NA, Ostrov D, Cance WG and Hochwald SN: A novel strategy to inhibit FAK and IGF-IR decreases growth of pancreatic cancer xenografts. Mol Carcinog 49: 200-209, 2010.
10. Lebrun P, Baron V, Hauck CR, Schlaepfer DD and Van Obberghen E: Cell adhesion and focal adhesion kinase regulate insulin receptor substrate-1 expression. J Biol Chem 275: 38371-38377, 2000. (Pubitemid 32009160)
11. El Annabi S, Gautier N and Baron V: Focal adhesion kinase and Src mediate integrin regulation of insulin receptor phosphorylation. FEBS Lett 507: 247-252, 2001. (Pubitemid 33030244)
12. Grobmyer SR, Reith JD, Shahlaee A, Bush CH and Hochwald SN: Malignant peripheral nerve sheath tumor: Molecular pathogenesis and current management considerations. J Surg Oncol 97: 340-349, 2008. (Pubitemid 351358582)
13. Ferner RE and Gutmann DH: International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 62: 1573-1577, 2002. (Pubitemid 34407825)
14. Kluwe L, Friedrich RE and Mautner VF: Allelic loss of the NF-1 gene in NF1-associated plexiform neurofibromas. Cancer Genet Cytogenet 113: 65-69, 1999. (Pubitemid 29354096)
15. Kourea HP, Cordon-Cardo C, Dudas M, Leung D and Wodruff JM: Expression of p27 kip and other cell cycle regulators in malignant peripheral nerve sheath tumors of neurofibromas. Am J Pathol 155: 1885-1891, 1999.
16. Nielsen GP, Stemmer-Rachamimov AO, Ino Y, Moller MB, Rosenberg AE and Louis DN: Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am J Path 155: 1879-1884, 1999.
17. Ling BC, Wu J and Miller SJ: Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis. Cancer Cell 7: 65-75, 2005. (Pubitemid 40126383)
18. Li H, Velasco-Miguel S, Vass WC, Parada LF and DeClue JE: Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the nfl:p53 mouse tumor model. Cancer Res 62: 4507-4513, 2002. (Pubitemid 34827315)
19. Friedrich RE, Keiner D and Hagel C: Expression of insulin-like growth factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1. Anticancer Res 27: 2085-90, 2007. (Pubitemid 46954729)
20. Scotlandi K, Manara MC, Serra M, Marino MT, Ventura S, Garofalo C, Alberghini M, Magagnoli G, Ferrari S, Lopez-Guerrero JA, Llombard-Bosch A and Picci P: Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survival. Eur J Cancer 47: 1258-1266, 2011.
21. Mardilovich K, Pankratz SL and Shaw LM: Expression and function of the insulin receptor substrate proteins in cancer. Cell Commun Signal 7: 14, 2009.
22. Shaw LM: The insulin receptor substrate (IRS) proteins: at the intersection of metabolism and cancer. Cell Cycle 10: 1750-1756, 2011.
23. Chan BT and Lee AV: Insulin receptor substrates (IRSs) and breast tumorigenesis. J Mammary Gland Biol Neoplasia 13: 415-422, 2008.